JAK inhibitors and other oral immunology drugs on every 2026 Maine Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Maine cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | Wellcare Classic$0.00/moS4802-075 | Wellcare Value Script$0.00/moS4802-136 | HealthSpring Assurance Rx$0.00/moS5617-003 | Humana Basic Rx Plan$0.00/moS5884-101 | Humana Value Rx Plan$54.40/moS5884-181 | AARP Medicare Rx Saver from UHC$82.40/moS5921-378 | SilverScript Choice$94.90/moS5601-002 | AARP Medicare Rx Preferred from UHC$104.30/moS5921-384 | Humana Premier Rx Plan$150.20/moS5884-148 |
|---|---|---|---|---|---|---|---|---|---|
| Rinvoqupadacitinib | Tier 5PA25%QL 360/30d | Tier 5PA25%QL 360/30d | Tier 5PA25%QL 360/30d | Tier 5PA25%QL 360/30d | Tier 5PA26%QL 360/30d | Not covered | Tier 5PA25%QL 360/30d | Tier 5PA31%QL 360/30d | Tier 5PA33%QL 360/30d |
| Xeljanztofacitinib | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Olumiantbaricitinib | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Otezlaapremilast | Tier 5PA25%QL 60/30d | Tier 5PA25%QL 60/30d | Tier 5PA25%QL 60/30d | Not covered | Not covered | Tier 5PA25%QL 60/30d | Not covered | Tier 5PA31%QL 60/30d | Not covered |
| Sotyktudeucravacitinib | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25%QL 30/30d | Tier 5PA31%QL 30/30d | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.